Meghan Verena Joyce - 03 Mar 2025 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Director
Signature
/s/ John G. Saia, as attorney-in-fact for Meghan Verena Joyce
Issuer symbol
GH
Transactions as of
03 Mar 2025
Net transactions value
-$4,271
Form type
4
Filing time
05 Mar 2025, 16:48:14 UTC
Previous filing
05 Feb 2025
Next filing
07 Apr 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH Common Stock Sale $4,271 -100 -1.3% $42.71 7,647 03 Mar 2025 Direct
transaction GH Common Stock Options Exercise $0 +67 +0.88% $0.000000 7,714 04 Mar 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH Restricted Stock Units Options Exercise $0 -67 -17% $0.000000 332 04 Mar 2025 Common Stock 67 $0.000000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The restricted stock unit vested as to 25% of the shares subject to the award on August 4, 2022, and the remaining 75% of the shares subject to such award vests in substantially equal installments on each monthly anniversary of August 4, 2022 during the three-year period thereafter.
F2 Not applicable for Restricted Stock Units.